Tag: Piramal Pharma Solutions
Piramal Pharma announces completion of 20% strategic growth investment by Carlyle
Carlyle completes investment in Piramal Pharma; capital infusion to accelerate Piramal Pharma’s organic and inorganic growth plans. Carlyle’s global healthcare expertise to bring significant value to Piramal Pharma..........................
Piramal Pharma partners Bolt Biotherapeutics for immune-stimulating antibody conjugates & sterile...
Piramal Pharma Solutions (PPS) is handling the production of Bolt’s Boltbody™ Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, currently in a first-in-human Phase 1/2 clinical study for the treatment of cancer patients.....................